J David Warren
Has grant
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Next-generation Fluorescent Probes for Biological Research
Open Date: 2012-09-10
Close Date: 2016-04-30
Grant: Close
Targeting vFLIP for the treatment of KSHV-associated malignancies
Open Date: 2011-03-15
Close Date: 2016-01-31
Grant: Close
Mycobacterial Proteasome Inhibitors
Open Date: 2010-06-21
Close Date: 2011-05-31
Grant: Close
Targeting Breast Cancer by Active Immunotherapy: Chemical Synthesis of Multiantigenic Unimolecular Antitumor Vaccines
Open Date: 2003-06-01
Close Date: 2006-06-30
Articles (10)
Objective: Diabetic foot wounds pose many challenges during the healing process and often become hard-to-heal (chronic) wounds. This study compared a novel botanical hydrogel with a widely used hydrogel to determine both its non-inferiority and impact on the progress of diabetic foot wounds. Method: The study was a prospective, double-blinded, randomised controlled study comparing healing outcomes. There were two cohorts: one treated with LAVIOR Diabetic Wound Gel (LDWG; Lavior Pharma Inc., US), which contains botanical extracts, and the other treated with SoloSite Wound Gel (SSWG) (Smith+Nephew Inc., US). The wounds were treated and evaluated weekly over a six-week period. Subjective patient data were collected with the Diabetic Foot Scale (DFS) at each visit. Results: The study cohort comprised 65 patients: 34 patients treated with LDWG, and 31 patients treated with SSWG. The patients treated with LDWG demonstrated at least as much progress in healing as those treated with SSWG. There was a greater reduction in wound surface area in the LDWG group from baseline to the end of the study (7.32cm 2 to 2.24cm 2 ) than in the SSWG group (8.18cm 2 to 5.16cm 2 ) (p=0.127). Reduction in pain was significantly improved in wounds treated with LDWG compared with SSWG (during follow-up weeks 1–4; p<0.001; week 5 was not statistically significant). The LDWG group demonstrated significantly greater improvement in DFS scores by the end of the study (scores of 192 versus 219, respectively, compared with the SSWG group; p=0.001). Wound closure times were comparable between the two groups. Conclusion: In this study, LDWG demonstrated non-inferiority to SSWG; better results were observed in pain reduction and surface area reduction. Further study is indicated.
Year:
2025
e14635 Background: Recent advances in computational pathology have revolutionized the analysis of histopathology images, enabling precise and rapid clinical outcome predictions. However, a significant challenge persists in translating computational insights into biologically meaningful data that informs clinical decisions. Human-interpretable image features (HIFs) have emerged as a solution, offering a detailed view of the tumor microenvironment (TME). In this study, we explored how HIFs derived from high-resolution histopathology images can predict the expression of genes associated with poor survival outcomes in stomach adenocarcinoma (STAD), aiming to bridge the gap between computational pathology and actionable clinical insights. Methods: Whole-slide histopathology images of STAD from The Cancer Genome Atlas were analyzed. Expert pathologists annotated labels were used to identify tissue types like cancer, stroma, necrosis, and normal tissue and cell types, including cancer cells, lymphocytes, macrophages, plasma cells, and fibroblasts. Using these annotations, convolutional neural networks were trained to classify these tissue and cell types, from which HIFs were extracted reflecting the biological composition of the TME, such as cell density ratios relative to surrounding tissues. We then identified genes with strong correlations to HIFs (ρ > 0.5) for further analysis. Results: Our results revealed high expression of four genes ABCA6, ABCA8, ADAM33, and ADAMTS10 that were significantly associated with poor survival outcomes in STAD (p 0.5 and p = 0.5a and p = < 0.01) with a high macrophage-to-stroma density ratio. This feature represents an immunosuppressive TME, often seen in aggressive and invasive cancers. Conclusions: These findings underscore the power of HIFs to reveal key TME characteristics. A stromal-dominant TME, defined by elevated ABCA6 and ABCA8 , and an immunosuppressive, macrophage-rich environment associated with increased ADAM33 and ADAMTS10 , serve as markers of disease aggressiveness and poor prognosis. By integrating these insights into AI-driven models, clinicians may identify high-risk patients earlier in their treatment journey, enabling personalized treatment strategies to improve outcomes for STAD patients.
Year:
2025
e16088 Background: Recent breakthroughs in computational pathology have transformed how we analyze histopathology images, making it possible to predict clinical outcomes with incredible precision and speed. Yet, a key challenge remains: how do we turn these computational insights into something biologically meaningful that can guide real-world clinical decisions? That’s where human-interpretable image features (HIFs) come in. HIFs offer a detailed look at the tumor microenvironment (TME), helping us understand complex biological interactions in a way that makes sense for clinical care. In this study, we explored how HIFs derived from high-resolution histopathology images could predict the expression of genes linked to therapeutic response in stomach adenocarcinoma (STAD). Methods: Using whole-slide histopathology images and clinical data from The Cancer Genome Atlas, we analyzed the tumor microenvironment of therapeutically responsive and resistance patients. Expert pathologists annotated key features of the tissue samples were used to identify areas such as cancer, stroma, necrosis, and normal tissue, as well as different cell types like cancer cells, lymphocytes, macrophages, plasma cells, and fibroblasts. These annotations are used to train convolutional neural network for pattern recognition and HIF identification which are features that capture the biological makeup of the TME. We focussed on the genes that showed significant differences between therapeutic resistance vs responders (p 0.4). Results: One of the most intriguing findings was that lower expression of a gene called LMNB1 was strongly linked to therapeutic resistance in STAD (p 0.45, p = 0.005) with a specific HIF: the number of cancer cells within the detection range of lymphocytes. This relationship has significant biological and clinical implications. A high value for this HIF suggests that immune cells, such as lymphocytes, are actively engaging with a large portion of the tumor, which indicates a tumor environment well-penetrated by immune cells. Conclusions: This immune engagement may have major implications for treatment. High levels of immune infiltration often create a favorable environment for therapies like immune checkpoint inhibitors. The elevated LMNB1 expression was also associated with aggressive disease and, suggesting it could serve as a marker to identify high-risk patients. These findings demonstrate the power of HIFs to provide a window into the complex dynamics of the TME. By integrating this knowledge into AI-driven models, clinicians could potentially identify high-risk patients earlier in their treatment journey and design personalized treatment strategies tailored to their specific tumor biology.
Year:
2025
Year:
2024
Lysosomes actively regulate their lumenal pH, which is necessary for optimal enzymatic activity. Endocytic processes are involved in many diseases, including Alzheimer’s disease, in which sub-optimal lysosomal function has been reported. To measure acidification, pH-sensitive probes can be delivered to endosomes and lysosomes using labeled dextran polymers or proteins. However, many commercially available probes have limited sensitivity in the acidic range of lysosomes, and their fluorescence is subject to enzymatic degradation and photobleaching. Herein, we describe the preparation, characterization, and use of a novel pH-sensitive probe, ApHID , a green-emitting fluorescent dye with optimal dynamic range within the acidity of endosomes and lysosomes. ApHID has a pKa near 5, increasing brightness with acidity, and it is robustly resistant to oxidation and photobleaching. We used ApHID ratiometric imaging to measure lysosomal pH in macrophages, yielding virtually identical results when compared with fluorescein and Oregon Green. Overall, ApHID circumvents limitations presented by most commercially available pH-sensitive probes and can be useful in demanding imaging applications such as intravital imaging of tissues.
Year:
2024
Year:
2023
Year:
2023
Year:
2021
Year:
2021
Year:
2020
Collaborators (3)
Francis Barany
Professor
Weill Cornell Medicine
Frederick Maxfield
Weill Cornell Medical College
Santiago Sole Domenech
Assistant Professor of Research
Weill Cornell Medicine
Make your next move.
Prepare your application
Review drafts before you send them.